Literature DB >> 19818070

The antiapoptotic activity of melatonin in neurodegenerative diseases.

Xin Wang1.   

Abstract

Melatonin plays a neuroprotective role in models of neurodegenerative diseases. However, the molecular mechanisms underlying neuroprotection by melatonin are not well understood. Apoptotic cell death in the central nervous system is a feature of neurodegenerative diseases. The intrinsic and extrinsic apoptotic pathways and the antiapoptotic survival signal pathways play critical roles in neurodegeneration. This review summarizes the reports to date showing inhibition by melatonin of the intrinsic apoptotic pathways in neurodegenerative diseases including stroke, Alzheimer disease, Parkinson disease, Huntington disease, and amyotrophic lateral sclerosis. Furthermore, the activation of survival signal pathways by melatonin in neurodegenerative diseases is discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19818070      PMCID: PMC2846661          DOI: 10.1111/j.1755-5949.2009.00105.x

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  137 in total

1.  Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study.

Authors:  Camila Andrade Mendes Medeiros; Pedro Felipe Carvalhedo de Bruin; Lívia Ariane Lopes; Maria Cecília Magalhães; Maria de Lourdes Seabra; Veralice Meireles Sales de Bruin
Journal:  J Neurol       Date:  2007-04-03       Impact factor: 4.849

2.  Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked.

Authors:  J Yang; X Liu; K Bhalla; C N Kim; A M Ibrado; J Cai; T I Peng; D P Jones; X Wang
Journal:  Science       Date:  1997-02-21       Impact factor: 47.728

3.  Melatonin reduces quinolinic acid-induced lipid peroxidation in rat brain homogenate.

Authors:  G Southgate; S Daya
Journal:  Metab Brain Dis       Date:  1999-09       Impact factor: 3.584

4.  Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice.

Authors:  Shan Zhu; Irina G Stavrovskaya; Martin Drozda; Betty Y S Kim; Victor Ona; Mingwei Li; Satinder Sarang; Allen S Liu; Dean M Hartley; Du Chu Wu; Steven Gullans; Robert J Ferrante; Serge Przedborski; Bruce S Kristal; Robert M Friedlander
Journal:  Nature       Date:  2002-05-02       Impact factor: 49.962

5.  Blood 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and melatonin levels in patients with either Huntington's disease or chronic brain injury.

Authors:  J Christofides; M Bridel; M Egerton; G M Mackay; C M Forrest; N Stoy; L G Darlington; T W Stone
Journal:  J Neurochem       Date:  2006-03-29       Impact factor: 5.372

6.  Early nuclear translocation of endonuclease G and subsequent DNA fragmentation after transient focal cerebral ischemia in mice.

Authors:  Byung I Lee; Doo J Lee; Kyoung J Cho; Gyung W Kim
Journal:  Neurosci Lett       Date:  2005-09-23       Impact factor: 3.046

7.  [The protective effects of melatonin on global cerebral ischemia-reperfusion injury in gerbils].

Authors:  Jing Zhang; Ji-dong Guo; Shu-hua Xing; Shu-ling Gu; Ti-jun Dai
Journal:  Yao Xue Xue Bao       Date:  2002-05

8.  Melatonin attenuates the focal cerebral ischemic injury by inhibiting the dissociation of pBad from 14-3-3.

Authors:  Phil-Ok Koh
Journal:  J Pineal Res       Date:  2008-01       Impact factor: 13.007

9.  The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH(2)-terminal kinase.

Authors:  Kui Lei; Anjaruwee Nimnual; Wei-Xing Zong; Norman J Kennedy; Richard A Flavell; Craig B Thompson; Dafna Bar-Sagi; Roger J Davis
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

10.  Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease.

Authors:  Philip R Gehrman; Donald J Connor; Jennifer L Martin; Tamar Shochat; Jody Corey-Bloom; Sonia Ancoli-Israel
Journal:  Am J Geriatr Psychiatry       Date:  2009-02       Impact factor: 4.105

View more
  57 in total

Review 1.  Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Authors:  Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Gregory M Brown; D Warren Spence; Vijay K Bharti; Charanjit Kaur; Rüdiger Hardeland; Daniel P Cardinali
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

2.  The Effect of Melatonin on Behavioral, Molecular, and Histopathological Changes in Cuprizone Model of Demyelination.

Authors:  Gelareh Vakilzadeh; Fariba Khodagholi; Tahereh Ghadiri; Amir Ghaemi; Farshid Noorbakhsh; Mohammad Sharifzadeh; Ali Gorji
Journal:  Mol Neurobiol       Date:  2015-08-27       Impact factor: 5.590

Review 3.  Neuroprotection for amyotrophic lateral sclerosis: role of stem cells, growth factors, and gene therapy.

Authors:  Rachna S Pandya; Lilly L J Mao; Edward W Zhou; Robert Bowser; Zhenglun Zhu; Yongjin Zhu; Xin Wang
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2012-03

Review 4.  [Huntington's disease].

Authors:  J D Rollnik
Journal:  Nervenarzt       Date:  2015-06       Impact factor: 1.214

5.  Protective effects of perfluorooctyl-bromide nanoparticles on early brain injuries following subarachnoid hemorrhage in rats.

Authors:  Huan Zhang; Rui Xu; Fei Xie; Wei Xu; Meng-Fei Zeng; Xin Wang; Ji Zhu
Journal:  Am J Transl Res       Date:  2015-08-15       Impact factor: 4.060

6.  Joint protective effect of exogenous neuroglobin and hemin in rat focal ischemic brain tissues.

Authors:  Fei Xie; Rui Xu; Xue Song; Haiyuan Zhu; Xin Wang; Ji Zhu
Journal:  Int J Clin Exp Med       Date:  2014-08-15

7.  Nose-to-brain transport of melatonin from polymer gel suspensions: a microdialysis study in rats.

Authors:  R Jayachandra Babu; Pankaj Patrick Dayal; Kasturi Pawar; Mandip Singh
Journal:  J Drug Target       Date:  2011-03-23       Impact factor: 5.121

8.  Treatment with melatonin after onset of experimental uveitis attenuates ocular inflammation.

Authors:  P H Sande; D Dorfman; D C Fernandez; M Chianelli; A P Domínguez Rubio; A M Franchi; D M Silberman; R E Rosenstein; D A Sáenz
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

9.  N-acetyl-serotonin offers neuroprotection through inhibiting mitochondrial death pathways and autophagic activation in experimental models of ischemic injury.

Authors:  Hua Zhou; Jian Wang; Jiying Jiang; Irina G Stavrovskaya; Mingchang Li; Wei Li; Qiaofeng Wu; Xinmu Zhang; Chengliang Luo; Shuanhu Zhou; Ana C Sirianni; Sovan Sarkar; Bruce S Kristal; Robert M Friedlander; Xin Wang
Journal:  J Neurosci       Date:  2014-02-19       Impact factor: 6.167

Review 10.  Therapeutic neuroprotective agents for amyotrophic lateral sclerosis.

Authors:  Rachna S Pandya; Haining Zhu; Wei Li; Robert Bowser; Robert M Friedlander; Xin Wang
Journal:  Cell Mol Life Sci       Date:  2013-07-18       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.